SlideShare a Scribd company logo
1 of 26
PCI Without On-Site Cardiac Surgery

                   Recent Meta-analyses

           Gregory J. Dehmer, MD, FACC, FACP, FAHA, FSCAI
                               Director, Cardiology Division
                                 Scott & White Healthcare
  Professor of Medicine, Texas A&M University Health Science Center College of Medicine
         Past President, Society for Cardiovascular Angiography and Interventions
                    Board of Trustees, American College of Cardiology



               We are all somewhat conflicted on this topic

     I perform PCIs at facilities with and without onsite cardiac surgery
PCI Without On-Site Surgery

There are really two questions

1. Is it safe to perform elective PCI
   without on-site surgery?
Studies on PCI Without On-Site Backup
Over 50 published peer-reviewed studies
• Most are retrospective reviews or prospective registries with a few
  non-blinded randomized trials
• Some only primary PCI, some only elective PCI, some mixed
    – Primary PCI: 1993 through 2008
    – Elective PCI: 1990 through 2012
    – Changing treatment paradigms
        • Fibrinolytic therapy before PCI; GPIIb/IIIa inhibitors; Stents

• Simple aggregation or meta-analysis can be problematic
    – All subject to unintentional bias or methodological concerns (changing
      treatment paradigms)
    – Many do not discriminate between
        • Emergency CABG for failed PCI vs.               CABG during
        • CABG after unsuccessful PCI vs.                 index admission
        • Urgent CABG for “discovered anatomy”
Singh M, et al. JAMA - 12/14/11
Singh M, et al. JAMA - 12/14/11
Characteristics of study
•    Used established guidelines (MOOSE*)
     for identifying studies

•    Data extraction well-described

•    Used an established tool (STROBE**)
     for evaluating the quality of the studies

•    Only studies with a control group
     considered

•    Heterogeneity of effect size evaluated

•    Publication bias examined

•    Effect of outliers evaluated

       Examined in-hospital mortality
         Rate of emergency CABG

    * Meta-analysis Of Observational Studies in Epidemiology
    **Strengthening the Reporting of Observational Studies in
    Epidemiology
Singh M, et al. JAMA - 12/14/11

                          1988
                           to    Mixed
N=15      International   2007




                                         n=124,074   n=914,288
STEMI Patients - Mortality




Key Points
• 11 studies
• Ave. mortality
    • No onsite surgery = 4.6%
    • Onsite surgery = 5.1%

           No difference in mortality
           OR = 0.96 (CI 0.88 – 1.05)
Non-primary PCI - Mortality




Key Points
• 9 studies
• Ave. mortality
    • No onsite surgery = 0.9%
  AfterOnsite surgery = 0.8%
    • adjustment for publication bias
   Mortality was 25% higher at sites
         without on-site surgery
  OR = 1.25 (CI 1.01 – 1.53), p = 0.04
STEMI & Non-primary PCI - CABG



STEMI



              n=7



Non-primary


              n=6




  STEMI patients: Lower incidence of emergency CABG at facilities without onsite surgery
  Non-primary patients: No difference
Summary and Conclusions - STEMI
• In-hospital mortality and the need for emergency CABG
  were not increased at sites without onsite surgery
   – In fact the need for emergency CABG was lower at sites without
     onsite surgery

• Possible Interpretation:
   – Concern that borderline stable patients may not be transferred
     out for CABG, but then mortality should be higher at facilities
     without onsite surgery and it was not
   – Alternatively, higher CABG rates at facilities with onsite surgery
     may reflect a lower threshold to opt for surgery if the results are
     suboptimal
Summary and Conclusions – Non-Primary PCI
• In-hospital mortality was not significantly different, but
  after adjustment for publication bias was 25% higher
  (barely) at facilities without onsite surgery
• Rate of emergency CABG was very low and not different

• Possible Interpretation:
     – Studies did not differentiate truly low risk elective patients from higher
       risk patients with unstable angina or NSTEMI
     – Patients in studies that adhered to all structure and process
       recommendations tend to do better
     – Patients at sites without onsite surgery or PCI capability are less likely
       to receive guideline recommended therapies1,2
     – The issue of volume-outcome relationship mentioned

1. Pride YB, et al. Circ Cardiovasc Qual Outcomes. 2009;2(6):574-582.
2. Pride YB, et al. JACC Cardiovasc Interv. 2009; 2(10):944-952.
Post PN, et al. Eur Heart J 2010
Post PN, et al. Eur Heart J 2010
Characteristics of study
•   Screened 1624 potential papers
    resulting in 10 PCI studies

•   1746 facilities; 1,322,342 patients

•   Used established guidelines
    (MOOSE) for identifying studies

•   Data extraction well-described

•   Heterogeneity of effect size
    evaluated; publication bias
    examined

•   Outcome variable: in-hospital
    mortality

•   Cut point for high vs. low volume
    cases differed but in most studies
    used was > 400 annually
Post PN, et al. Eur Heart J 2010




                                                         OR 0.87




Corrections for heterogeneity and eliminating certain studies failed to alter the OR
of the result

Consideration of stent used did not affect the results either
Surgery Onsite in the NCDR
•   1298 facilities     About 4% of
    reporting in the     the PCIs

    NCDR

•   49% ≤ 400 PCIs
    annually

•   26% ≤ 200 PCIs
    annually

•   Preponderance of
    sites without
    surgery are lower
    volume sites (22%
    ≤ 200 annually


                                      Dehmer GJ, et al. JACC Nov 13, 2012
Zia MI, et al. Can J Cardiol - 2011
Zia MI, et al. Can J Cardiol -2011


Characteristics of study
•    Data extraction well-described and used
     established methods
•    Randomized studies and those without a
     control group considered
•    Heterogeneity of effect size evaluated
•    Publication bias examined, but none
     found
                                               n=11
•    Effect of outliers evaluated


         Examined in-hospital mortality
                                               n=18
           Rate of emergency CABG
STEMI Patients
                        Key Points
In-hospital Mortality                                         Early CABG
                        •   9 studies ( 6 same as Singh)
                              • 8607 pts. without and
                                 97,386 with onsite surgery

                        •   Ave. mortality
                              • No onsite surgery = 6.1%
                              • Onsite surgery = 7.6%

                              No difference in mortality
                             OR = 0.93 (CI 0.83 – 1.05)

                        •   Early CABG
                             • No onsite surgery = 3.0%
                             • Onsite surgery = 3.4%


                            No difference in early CABG
                             OR = 0.87 (CI 0.68 – 1.11)
Non-Primary PCI Patients
                            Key Points
In-hospital Mortality                                              Early CABG
                            •   6 studies (6 same as Singh)
                                  • 28,552 pts. without and
                                     881,261 with onsite surgery

                            •   Ave. mortality
                                  • No onsite surgery = 1.6%
                                  • Onsite surgery = 2.1%

                                   No difference in mortality
                                  OR = 1.03 (CI 0.64 – 1.66)

                            •   Early CABG
                                 • No onsite surgery = 1.0%
                                 • Onsite surgery = 0.9%

                                 No difference in early CABG
                                 OR = 1.38 (CI 0.65 – 2.95)

                        However, heterogeneity of results noted
Summary and Conclusions – Zia Meta-analysis

• STEMI patients: No difference in the in-hospital mortality
  or early CABG among sites with and without onsite
  surgery

• Non-primary PCI: Overall, no difference in the in-hospital
  mortality or early CABG among sites with and without
  onsite surgery
    – But, substantial variation in outcomes among sites
    – Although centers with and without onsite surgery can achieve
      similar outcomes, monitoring to ensure safety and efficacy of
      each PCI center without cardiac surgery is of paramount
      importance.
•
Singh PP, et al. Am J Therapeutics - 2011




         American J Therapeutics 2011; 18:e22-e28.
Singh PP, et al. Am J Therapeutics - 2011

Characteristics of study
•   Data extraction well-described and
    used established methods
•   Heterogeneity evaluated, but none
    found
•   Only studies with a comparison group
    considered
•   Publication bias not evaluated
•   4 studies (n = 6,817 patients)

     Examined:
     1. All cause in-hospital death
     2. Non-fatal MI
     3. Emergency CABG (unplanned surgery
        within 48 hours)
Singh PP, et al. Am J Therapeutics - 2011

               Summary of Analysis




2 studies

4 studies


2 studies
PCI Without On-Site Surgery

There are really two questions
1.   Is it safe to perform PCI without on-site
     surgery?
     •   STEMI patients - YES
         •   No difference in mortality or CABG

     •   Non-primary patients – PROBABLY YES
         •   No difference in CABG, possible signal of
             increased mortality in one meta-analysis
PCI Without On-Site Surgery

There are really two questions

1. Is it safe to perform PCI without
   on-site surgery?

2. What is the right way to
   provide PCI services in New
   Jersey and the US?
The “Real” Bottom Line
• This is really about developing a quality-driven system of
  care for patients needing PCI
   – The quality of a program is not determined solely by the
     presence of absence of a surgeon
   – The decision to operate a program should be based on the
     needs of patients and the community
   – “Ensuring that all PCI programs meet appropriate
     performance metrics is likely to save more lives than
     requiring all PCI
                                Released February 5, 2007 Full document at:   www.scai.org
     programs to have
     on-site cardiac surgery”

More Related Content

What's hot

Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...Institute for Clinical Research (ICR)
 
Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)BartsMSBlog
 
Clinical trial options for rare diseases
Clinical trial options for rare diseasesClinical trial options for rare diseases
Clinical trial options for rare diseasesAlbert Farrugia
 
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...Institute for Clinical Research (ICR)
 
Residual Non-Funtioning Pituitary Adenoma
Residual Non-Funtioning Pituitary AdenomaResidual Non-Funtioning Pituitary Adenoma
Residual Non-Funtioning Pituitary AdenomaMQ_Library
 
MAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & ResultsMAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & Resultstheheart.org
 
Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)
Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)
Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)BartsMSBlog
 
Cranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal ClubCranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal ClubMQ_Library
 
Actrims 2016 oratorio lb poster wolinsky_lb148
Actrims 2016 oratorio lb poster wolinsky_lb148Actrims 2016 oratorio lb poster wolinsky_lb148
Actrims 2016 oratorio lb poster wolinsky_lb148BartsMSBlog
 
IPCV MGT WITH PDT
IPCV MGT WITH PDTIPCV MGT WITH PDT
IPCV MGT WITH PDTAjayDudani1
 
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053BartsMSBlog
 
Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015Jon Sweet
 
Actrims 2016 opera poster hauser_p024 (1)
Actrims 2016 opera poster hauser_p024 (1)Actrims 2016 opera poster hauser_p024 (1)
Actrims 2016 opera poster hauser_p024 (1)BartsMSBlog
 
The place of baseline biopsy histology
The place of baseline biopsy histology The place of baseline biopsy histology
The place of baseline biopsy histology Maarten Naesens
 
Hypothermia in tbi for neuroprotection
Hypothermia in tbi for neuroprotectionHypothermia in tbi for neuroprotection
Hypothermia in tbi for neuroprotectionAbhishek Sharma
 
Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy
Hypothermia for Neonatal Hypoxic Ischemic EncephalopathyHypothermia for Neonatal Hypoxic Ischemic Encephalopathy
Hypothermia for Neonatal Hypoxic Ischemic EncephalopathyMaged Zakaria
 

What's hot (18)

Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
Safety and Efficacy of Low Dose versus Standard Dose of Alteplase for Stroke ...
 
Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)Actrims 2016 oratorio poster montalban_p023 (1)
Actrims 2016 oratorio poster montalban_p023 (1)
 
Clinical trial options for rare diseases
Clinical trial options for rare diseasesClinical trial options for rare diseases
Clinical trial options for rare diseases
 
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
Associated Factors of Stroke Severity Among Young Adult Stroke Patients in Ma...
 
Residual Non-Funtioning Pituitary Adenoma
Residual Non-Funtioning Pituitary AdenomaResidual Non-Funtioning Pituitary Adenoma
Residual Non-Funtioning Pituitary Adenoma
 
MAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & ResultsMAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & Results
 
Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)
Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)
Actrims 2016 oratorio lb platform wolinsky_lb1.3 (1)
 
Cranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal ClubCranioplasty jc Macquarie Neurosurgery Journal Club
Cranioplasty jc Macquarie Neurosurgery Journal Club
 
Actrims 2016 oratorio lb poster wolinsky_lb148
Actrims 2016 oratorio lb poster wolinsky_lb148Actrims 2016 oratorio lb poster wolinsky_lb148
Actrims 2016 oratorio lb poster wolinsky_lb148
 
IPCV MGT WITH PDT
IPCV MGT WITH PDTIPCV MGT WITH PDT
IPCV MGT WITH PDT
 
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
Coles alemtuzumab camm223 10yr efficacy safety aan 2016_poster p3.053
 
Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015Hospital Medicine Update, VA ACP Meeting 2015
Hospital Medicine Update, VA ACP Meeting 2015
 
Actrims 2016 opera poster hauser_p024 (1)
Actrims 2016 opera poster hauser_p024 (1)Actrims 2016 opera poster hauser_p024 (1)
Actrims 2016 opera poster hauser_p024 (1)
 
National Health Policy Forum (3/25/11)
National Health Policy Forum (3/25/11)National Health Policy Forum (3/25/11)
National Health Policy Forum (3/25/11)
 
The place of baseline biopsy histology
The place of baseline biopsy histology The place of baseline biopsy histology
The place of baseline biopsy histology
 
Hypothermia in tbi for neuroprotection
Hypothermia in tbi for neuroprotectionHypothermia in tbi for neuroprotection
Hypothermia in tbi for neuroprotection
 
Medical and Non-surgical Treatment of Peyronie's Disease
Medical and Non-surgical Treatment of Peyronie's DiseaseMedical and Non-surgical Treatment of Peyronie's Disease
Medical and Non-surgical Treatment of Peyronie's Disease
 
Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy
Hypothermia for Neonatal Hypoxic Ischemic EncephalopathyHypothermia for Neonatal Hypoxic Ischemic Encephalopathy
Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy
 

Viewers also liked

Korruptsion ja bürokraatia
Korruptsion ja bürokraatiaKorruptsion ja bürokraatia
Korruptsion ja bürokraatiaIlony Brunette
 
10 tips incentive-infographic
10 tips incentive-infographic10 tips incentive-infographic
10 tips incentive-infographicIncentive Inc
 
Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12
Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12 Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12
Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12 SydFleischer
 
Cờ Tướng - Quá cung pháo đối pháo đầu
Cờ Tướng - Quá cung pháo đối pháo đầuCờ Tướng - Quá cung pháo đối pháo đầu
Cờ Tướng - Quá cung pháo đối pháo đầuTran Tuan
 
Tablet hotels power point
Tablet hotels power pointTablet hotels power point
Tablet hotels power pointakram75015
 
PB Where Do You Draw the Line
PB Where Do You Draw the LinePB Where Do You Draw the Line
PB Where Do You Draw the Linechan0496
 
ขั้นตอนในการพัฒนาเว็บไซต์
ขั้นตอนในการพัฒนาเว็บไซต์ขั้นตอนในการพัฒนาเว็บไซต์
ขั้นตอนในการพัฒนาเว็บไซต์Suthida23
 
444 presentation
444 presentation444 presentation
444 presentationturkb
 
Continuity Editing
Continuity EditingContinuity Editing
Continuity EditingShiva Kumar
 
Notícia Carlos slim
Notícia Carlos slimNotícia Carlos slim
Notícia Carlos slimgemmalum
 
عرض محمد مطهر
عرض محمد مطهرعرض محمد مطهر
عرض محمد مطهرkhaledtawashi
 
Follow people on twitter
Follow people on twitterFollow people on twitter
Follow people on twittercbcampuscmh
 
Continuity editing
Continuity editingContinuity editing
Continuity editingShiva Kumar
 
Cờ Tướng - Khái niệm về cờ tướng trung cuộc
Cờ Tướng - Khái niệm về cờ tướng trung cuộcCờ Tướng - Khái niệm về cờ tướng trung cuộc
Cờ Tướng - Khái niệm về cờ tướng trung cuộcTran Tuan
 
Ebook outlook-sharepoint-dropbox-oh-my
Ebook outlook-sharepoint-dropbox-oh-myEbook outlook-sharepoint-dropbox-oh-my
Ebook outlook-sharepoint-dropbox-oh-myIncentive Inc
 
P World Population Trends
P World Population TrendsP World Population Trends
P World Population Trendschan0496
 
Asee Klub Ruma 2012. Vojislav Rodić
Asee Klub Ruma 2012. Vojislav RodićAsee Klub Ruma 2012. Vojislav Rodić
Asee Klub Ruma 2012. Vojislav RodićAdizesSEE
 
Posada los bucares
Posada los bucares Posada los bucares
Posada los bucares anakris0106
 

Viewers also liked (18)

Korruptsion ja bürokraatia
Korruptsion ja bürokraatiaKorruptsion ja bürokraatia
Korruptsion ja bürokraatia
 
10 tips incentive-infographic
10 tips incentive-infographic10 tips incentive-infographic
10 tips incentive-infographic
 
Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12
Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12 Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12
Causes.com & NFG Nonprofit 911 class: Community-based fundraising 12.4.12
 
Cờ Tướng - Quá cung pháo đối pháo đầu
Cờ Tướng - Quá cung pháo đối pháo đầuCờ Tướng - Quá cung pháo đối pháo đầu
Cờ Tướng - Quá cung pháo đối pháo đầu
 
Tablet hotels power point
Tablet hotels power pointTablet hotels power point
Tablet hotels power point
 
PB Where Do You Draw the Line
PB Where Do You Draw the LinePB Where Do You Draw the Line
PB Where Do You Draw the Line
 
ขั้นตอนในการพัฒนาเว็บไซต์
ขั้นตอนในการพัฒนาเว็บไซต์ขั้นตอนในการพัฒนาเว็บไซต์
ขั้นตอนในการพัฒนาเว็บไซต์
 
444 presentation
444 presentation444 presentation
444 presentation
 
Continuity Editing
Continuity EditingContinuity Editing
Continuity Editing
 
Notícia Carlos slim
Notícia Carlos slimNotícia Carlos slim
Notícia Carlos slim
 
عرض محمد مطهر
عرض محمد مطهرعرض محمد مطهر
عرض محمد مطهر
 
Follow people on twitter
Follow people on twitterFollow people on twitter
Follow people on twitter
 
Continuity editing
Continuity editingContinuity editing
Continuity editing
 
Cờ Tướng - Khái niệm về cờ tướng trung cuộc
Cờ Tướng - Khái niệm về cờ tướng trung cuộcCờ Tướng - Khái niệm về cờ tướng trung cuộc
Cờ Tướng - Khái niệm về cờ tướng trung cuộc
 
Ebook outlook-sharepoint-dropbox-oh-my
Ebook outlook-sharepoint-dropbox-oh-myEbook outlook-sharepoint-dropbox-oh-my
Ebook outlook-sharepoint-dropbox-oh-my
 
P World Population Trends
P World Population TrendsP World Population Trends
P World Population Trends
 
Asee Klub Ruma 2012. Vojislav Rodić
Asee Klub Ruma 2012. Vojislav RodićAsee Klub Ruma 2012. Vojislav Rodić
Asee Klub Ruma 2012. Vojislav Rodić
 
Posada los bucares
Posada los bucares Posada los bucares
Posada los bucares
 

Similar to PCI Safety Without On-Site Cardiac Surgery

Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020IACTSWeb
 
Predictive factors of in-hospital mortality in colorectal surgery
Predictive factors of in-hospital mortality in colorectal surgeryPredictive factors of in-hospital mortality in colorectal surgery
Predictive factors of in-hospital mortality in colorectal surgeryMichail Papoulas
 
Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)Alireza Ghorbani Sharif
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analysesevadew1
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016evadew1
 
Critical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trialsCritical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trialsSamir Haffar
 
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...Chaichuk Sergiy
 
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...HMO Research Network
 
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...HMO Research Network
 
Ppci culprit vs mv acad card 2013 mumbai
Ppci culprit vs mv acad card 2013 mumbaiPpci culprit vs mv acad card 2013 mumbai
Ppci culprit vs mv acad card 2013 mumbaicardiositeindia
 
Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...
Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...
Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...breastcancerupdatecongress
 
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...Diaa A. Hameed
 
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...GOPAL GHOSH
 
Cad and low ef does viability assessment matter
Cad and low ef does viability assessment matterCad and low ef does viability assessment matter
Cad and low ef does viability assessment matterdrucsamal
 
What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?kellyam18
 
Colorectal Cancer Screening for Family Physicians - What's New
Colorectal Cancer Screening for Family Physicians - What's NewColorectal Cancer Screening for Family Physicians - What's New
Colorectal Cancer Screening for Family Physicians - What's NewJarrod Lee
 

Similar to PCI Safety Without On-Site Cardiac Surgery (20)

Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
 
Predictive factors of in-hospital mortality in colorectal surgery
Predictive factors of in-hospital mortality in colorectal surgeryPredictive factors of in-hospital mortality in colorectal surgery
Predictive factors of in-hospital mortality in colorectal surgery
 
Courage TRIAL 2007
Courage TRIAL 2007Courage TRIAL 2007
Courage TRIAL 2007
 
Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)Should we implant icd only in some patients with nicmp (cons)
Should we implant icd only in some patients with nicmp (cons)
 
Technology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic AnalysesTechnology Assessment, Outcomes Research and Economic Analyses
Technology Assessment, Outcomes Research and Economic Analyses
 
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
Technology Assessment/Outcome & Cost-Effectiveness Analysis 2016
 
Carotid surgery 2014
Carotid surgery 2014Carotid surgery 2014
Carotid surgery 2014
 
Critical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trialsCritical appraisal of randomized clinical trials
Critical appraisal of randomized clinical trials
 
CARCINOMA CERVIX
CARCINOMA CERVIXCARCINOMA CERVIX
CARCINOMA CERVIX
 
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
Лечение пациентов с поражением ствола ЛКА, преимущества коронарной хирургии. ...
 
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
 
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
Patient Selection for Primary Prevention Implantable Cardioverter Defibrillat...
 
Stich trial.pptx
Stich trial.pptxStich trial.pptx
Stich trial.pptx
 
Ppci culprit vs mv acad card 2013 mumbai
Ppci culprit vs mv acad card 2013 mumbaiPpci culprit vs mv acad card 2013 mumbai
Ppci culprit vs mv acad card 2013 mumbai
 
Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...
Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...
Noa Efrat Ben Baruch : Oncotype Dx Breast Cancer Assay and impact on treatmen...
 
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...Neoadjuvant Chemotherapy in muscle invasive bladder cancer:The Standard of ...
Neoadjuvant Chemotherapy in muscle invasive bladder cancer: The Standard of ...
 
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
Coronary artery bypass grafting vs percutaneous coronary intervention in mult...
 
Cad and low ef does viability assessment matter
Cad and low ef does viability assessment matterCad and low ef does viability assessment matter
Cad and low ef does viability assessment matter
 
What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?What is the place of CT coronary angiography in ED chest pain?
What is the place of CT coronary angiography in ED chest pain?
 
Colorectal Cancer Screening for Family Physicians - What's New
Colorectal Cancer Screening for Family Physicians - What's NewColorectal Cancer Screening for Family Physicians - What's New
Colorectal Cancer Screening for Family Physicians - What's New
 

More from dwestenberger

G dangas jmc-c lurken
G dangas jmc-c lurkenG dangas jmc-c lurken
G dangas jmc-c lurkendwestenberger
 
Kutcher 11-27-12_final-x
 Kutcher 11-27-12_final-x Kutcher 11-27-12_final-x
Kutcher 11-27-12_final-xdwestenberger
 
Commissioner of health mary o'dowd
Commissioner of health   mary o'dowdCommissioner of health   mary o'dowd
Commissioner of health mary o'dowddwestenberger
 
Dr ken kutscher opening remarks
Dr ken kutscher opening remarksDr ken kutscher opening remarks
Dr ken kutscher opening remarksdwestenberger
 
Final program 11 27-12
Final program 11 27-12Final program 11 27-12
Final program 11 27-12dwestenberger
 

More from dwestenberger (9)

Brindis
BrindisBrindis
Brindis
 
G dangas jmc-c lurken
G dangas jmc-c lurkenG dangas jmc-c lurken
G dangas jmc-c lurken
 
Aversano
AversanoAversano
Aversano
 
Kutcher 11-27-12_final-x
 Kutcher 11-27-12_final-x Kutcher 11-27-12_final-x
Kutcher 11-27-12_final-x
 
Thomas wharton
Thomas whartonThomas wharton
Thomas wharton
 
Dennis presentation
Dennis presentationDennis presentation
Dennis presentation
 
Commissioner of health mary o'dowd
Commissioner of health   mary o'dowdCommissioner of health   mary o'dowd
Commissioner of health mary o'dowd
 
Dr ken kutscher opening remarks
Dr ken kutscher opening remarksDr ken kutscher opening remarks
Dr ken kutscher opening remarks
 
Final program 11 27-12
Final program 11 27-12Final program 11 27-12
Final program 11 27-12
 

PCI Safety Without On-Site Cardiac Surgery

  • 1. PCI Without On-Site Cardiac Surgery Recent Meta-analyses Gregory J. Dehmer, MD, FACC, FACP, FAHA, FSCAI Director, Cardiology Division Scott & White Healthcare Professor of Medicine, Texas A&M University Health Science Center College of Medicine Past President, Society for Cardiovascular Angiography and Interventions Board of Trustees, American College of Cardiology We are all somewhat conflicted on this topic I perform PCIs at facilities with and without onsite cardiac surgery
  • 2. PCI Without On-Site Surgery There are really two questions 1. Is it safe to perform elective PCI without on-site surgery?
  • 3. Studies on PCI Without On-Site Backup Over 50 published peer-reviewed studies • Most are retrospective reviews or prospective registries with a few non-blinded randomized trials • Some only primary PCI, some only elective PCI, some mixed – Primary PCI: 1993 through 2008 – Elective PCI: 1990 through 2012 – Changing treatment paradigms • Fibrinolytic therapy before PCI; GPIIb/IIIa inhibitors; Stents • Simple aggregation or meta-analysis can be problematic – All subject to unintentional bias or methodological concerns (changing treatment paradigms) – Many do not discriminate between • Emergency CABG for failed PCI vs. CABG during • CABG after unsuccessful PCI vs. index admission • Urgent CABG for “discovered anatomy”
  • 4. Singh M, et al. JAMA - 12/14/11
  • 5. Singh M, et al. JAMA - 12/14/11 Characteristics of study • Used established guidelines (MOOSE*) for identifying studies • Data extraction well-described • Used an established tool (STROBE**) for evaluating the quality of the studies • Only studies with a control group considered • Heterogeneity of effect size evaluated • Publication bias examined • Effect of outliers evaluated Examined in-hospital mortality Rate of emergency CABG * Meta-analysis Of Observational Studies in Epidemiology **Strengthening the Reporting of Observational Studies in Epidemiology
  • 6. Singh M, et al. JAMA - 12/14/11 1988 to Mixed N=15 International 2007 n=124,074 n=914,288
  • 7. STEMI Patients - Mortality Key Points • 11 studies • Ave. mortality • No onsite surgery = 4.6% • Onsite surgery = 5.1% No difference in mortality OR = 0.96 (CI 0.88 – 1.05)
  • 8. Non-primary PCI - Mortality Key Points • 9 studies • Ave. mortality • No onsite surgery = 0.9% AfterOnsite surgery = 0.8% • adjustment for publication bias Mortality was 25% higher at sites without on-site surgery OR = 1.25 (CI 1.01 – 1.53), p = 0.04
  • 9. STEMI & Non-primary PCI - CABG STEMI n=7 Non-primary n=6 STEMI patients: Lower incidence of emergency CABG at facilities without onsite surgery Non-primary patients: No difference
  • 10. Summary and Conclusions - STEMI • In-hospital mortality and the need for emergency CABG were not increased at sites without onsite surgery – In fact the need for emergency CABG was lower at sites without onsite surgery • Possible Interpretation: – Concern that borderline stable patients may not be transferred out for CABG, but then mortality should be higher at facilities without onsite surgery and it was not – Alternatively, higher CABG rates at facilities with onsite surgery may reflect a lower threshold to opt for surgery if the results are suboptimal
  • 11. Summary and Conclusions – Non-Primary PCI • In-hospital mortality was not significantly different, but after adjustment for publication bias was 25% higher (barely) at facilities without onsite surgery • Rate of emergency CABG was very low and not different • Possible Interpretation: – Studies did not differentiate truly low risk elective patients from higher risk patients with unstable angina or NSTEMI – Patients in studies that adhered to all structure and process recommendations tend to do better – Patients at sites without onsite surgery or PCI capability are less likely to receive guideline recommended therapies1,2 – The issue of volume-outcome relationship mentioned 1. Pride YB, et al. Circ Cardiovasc Qual Outcomes. 2009;2(6):574-582. 2. Pride YB, et al. JACC Cardiovasc Interv. 2009; 2(10):944-952.
  • 12. Post PN, et al. Eur Heart J 2010
  • 13. Post PN, et al. Eur Heart J 2010 Characteristics of study • Screened 1624 potential papers resulting in 10 PCI studies • 1746 facilities; 1,322,342 patients • Used established guidelines (MOOSE) for identifying studies • Data extraction well-described • Heterogeneity of effect size evaluated; publication bias examined • Outcome variable: in-hospital mortality • Cut point for high vs. low volume cases differed but in most studies used was > 400 annually
  • 14. Post PN, et al. Eur Heart J 2010 OR 0.87 Corrections for heterogeneity and eliminating certain studies failed to alter the OR of the result Consideration of stent used did not affect the results either
  • 15. Surgery Onsite in the NCDR • 1298 facilities About 4% of reporting in the the PCIs NCDR • 49% ≤ 400 PCIs annually • 26% ≤ 200 PCIs annually • Preponderance of sites without surgery are lower volume sites (22% ≤ 200 annually Dehmer GJ, et al. JACC Nov 13, 2012
  • 16. Zia MI, et al. Can J Cardiol - 2011
  • 17. Zia MI, et al. Can J Cardiol -2011 Characteristics of study • Data extraction well-described and used established methods • Randomized studies and those without a control group considered • Heterogeneity of effect size evaluated • Publication bias examined, but none found n=11 • Effect of outliers evaluated Examined in-hospital mortality n=18 Rate of emergency CABG
  • 18. STEMI Patients Key Points In-hospital Mortality Early CABG • 9 studies ( 6 same as Singh) • 8607 pts. without and 97,386 with onsite surgery • Ave. mortality • No onsite surgery = 6.1% • Onsite surgery = 7.6% No difference in mortality OR = 0.93 (CI 0.83 – 1.05) • Early CABG • No onsite surgery = 3.0% • Onsite surgery = 3.4% No difference in early CABG OR = 0.87 (CI 0.68 – 1.11)
  • 19. Non-Primary PCI Patients Key Points In-hospital Mortality Early CABG • 6 studies (6 same as Singh) • 28,552 pts. without and 881,261 with onsite surgery • Ave. mortality • No onsite surgery = 1.6% • Onsite surgery = 2.1% No difference in mortality OR = 1.03 (CI 0.64 – 1.66) • Early CABG • No onsite surgery = 1.0% • Onsite surgery = 0.9% No difference in early CABG OR = 1.38 (CI 0.65 – 2.95) However, heterogeneity of results noted
  • 20. Summary and Conclusions – Zia Meta-analysis • STEMI patients: No difference in the in-hospital mortality or early CABG among sites with and without onsite surgery • Non-primary PCI: Overall, no difference in the in-hospital mortality or early CABG among sites with and without onsite surgery – But, substantial variation in outcomes among sites – Although centers with and without onsite surgery can achieve similar outcomes, monitoring to ensure safety and efficacy of each PCI center without cardiac surgery is of paramount importance. •
  • 21. Singh PP, et al. Am J Therapeutics - 2011 American J Therapeutics 2011; 18:e22-e28.
  • 22. Singh PP, et al. Am J Therapeutics - 2011 Characteristics of study • Data extraction well-described and used established methods • Heterogeneity evaluated, but none found • Only studies with a comparison group considered • Publication bias not evaluated • 4 studies (n = 6,817 patients) Examined: 1. All cause in-hospital death 2. Non-fatal MI 3. Emergency CABG (unplanned surgery within 48 hours)
  • 23. Singh PP, et al. Am J Therapeutics - 2011 Summary of Analysis 2 studies 4 studies 2 studies
  • 24. PCI Without On-Site Surgery There are really two questions 1. Is it safe to perform PCI without on-site surgery? • STEMI patients - YES • No difference in mortality or CABG • Non-primary patients – PROBABLY YES • No difference in CABG, possible signal of increased mortality in one meta-analysis
  • 25. PCI Without On-Site Surgery There are really two questions 1. Is it safe to perform PCI without on-site surgery? 2. What is the right way to provide PCI services in New Jersey and the US?
  • 26. The “Real” Bottom Line • This is really about developing a quality-driven system of care for patients needing PCI – The quality of a program is not determined solely by the presence of absence of a surgeon – The decision to operate a program should be based on the needs of patients and the community – “Ensuring that all PCI programs meet appropriate performance metrics is likely to save more lives than requiring all PCI Released February 5, 2007 Full document at: www.scai.org programs to have on-site cardiac surgery”